FSA Wealth Management LLC Takes $74,000 Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

FSA Wealth Management LLC purchased a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 749 shares of the exchange traded fund’s stock, valued at approximately $74,000.

Several other hedge funds have also made changes to their positions in the stock. Healthcare of Ontario Pension Plan Trust Fund grew its position in SPDR S&P Biotech ETF by 198.6% in the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock worth $911,825,000 after purchasing an additional 6,138,000 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd acquired a new position in shares of SPDR S&P Biotech ETF during the third quarter worth approximately $141,284,000. Affinity Asset Advisors LLC grew its holdings in SPDR S&P Biotech ETF by 105.4% in the 2nd quarter. Affinity Asset Advisors LLC now owns 37,550 shares of the exchange traded fund’s stock worth $3,481,000 after buying an additional 737,550 shares in the last quarter. Mirae Asset Securities USA Inc. acquired a new stake in SPDR S&P Biotech ETF in the 2nd quarter valued at approximately $55,626,000. Finally, Assetmark Inc. raised its stake in SPDR S&P Biotech ETF by 72,653.0% during the 3rd quarter. Assetmark Inc. now owns 589,299 shares of the exchange traded fund’s stock valued at $58,223,000 after acquiring an additional 588,489 shares in the last quarter.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI opened at $99.62 on Monday. The firm has a market capitalization of $7.59 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a one year low of $74.20 and a one year high of $105.47. The stock’s fifty day moving average is $98.22 and its 200-day moving average is $96.61.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.